Christoph Broja is a Managing Director in the EQT Life Sciences team since 2022.
Before joining EQT, he was a Principal in the investment team at Gurnet Point Capital based in Boston, where he was involved in a number of investments in biopharma, medical devices, and molecular diagnostics. Prior to that, Christoph worked at B-Flexion Capital in London.
Christoph started his career as investment analyst at private equity firm Franz Haniel & Cie. in Germany. He holds a degree in Business Administration and is a CFA Charterholder.